UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial

Clinical cancer research, 2012-04, Vol.18 (8), p.2402-2412

2012

Volltextzugriff (PDF)

Updated UK Recommendations for HER2 assessment in breast cancer

Journal of clinical pathology, 2015-02, Vol.68 (2), p.93-99

2015

Volltextzugriff (PDF)

Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells

Oncogene, 2016-05, Vol.35 (21), p.2766-2776

2016

Volltextzugriff (PDF)

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

The Journal of pathology, 2008-08, Vol.215 (4), p.398-410

2008

Volltextzugriff (PDF)

Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer

Oncogene, 2017-04, Vol.36 (16), p.2319-2327

2017

Volltextzugriff (PDF)

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

Journal of clinical oncology, 2021-11, Vol.39 (32), p.3623-3632

2021

Volltextzugriff (PDF)

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

The Lancet (British edition), 2017-09, Vol.390 (10099), p.1048-1060

2017

Volltextzugriff (PDF)

Lasofoxifene in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2010-02, Vol.362 (8), p.686-696

2010

Volltextzugriff (PDF)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

British journal of cancer, 2010-08, Vol.103 (5), p.668-675

2010

Volltextzugriff (PDF)

Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia

Journal of translational medicine, 2019-02, Vol.17 (1), p.60-60, Article 60

2019

Volltextzugriff (PDF)

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

The Lancet (British edition), 2019-04, Vol.393 (10179), p.1440-1452

2019

Volltextzugriff (PDF)

TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? - Results of an international retrospective multicenter study

Clinical immunology (Orlando, Fla.), 2022-05, Vol.238, p.109018-109018, Article 109018

2022

Volltextzugriff (PDF)

Body-Mass Index and Mortality among Adults with Incident Type 2 Diabetes

The New England journal of medicine, 2014-01, Vol.370 (3), p.233-244

2014

Volltextzugriff (PDF)

A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.15-23

2021

Volltextzugriff (PDF)

Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14

Euro surveillance : bulletin européen sur les maladies transmissibles, 2014-11, Vol.19 (45), p.20959-20959

2014

Volltextzugriff (PDF)

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

The New England journal of medicine, 2015-11, Vol.373 (21), p.2005-2014

2015

Volltextzugriff (PDF)

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2889-2895

2003

Volltextzugriff (PDF)

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

The New England journal of medicine, 2015-07, Vol.373 (3), p.209-219

2015

Volltextzugriff (PDF)

Phase III Comparison of Standard Doxorubicin and Cyclophosphamide Versus Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor As Neoadjuvant Therapy for Inflammatory and Locally Advanced Breast Cancer: SWOG 0012

Journal of clinical oncology, 2011-03, Vol.29 (8), p.1014-1021

2011

Volltextzugriff (PDF)

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

Clinical cancer research, 2017-06, Vol.23 (12), p.2991-3002

2017

Volltextzugriff (PDF)

Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation

The New England journal of medicine, 2002-05, Vol.346 (21), p.1609-1615

2002

Volltextzugriff (PDF)

Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001)

European journal of cancer (1990), 2014-09, Vol.50 (14), p.2375-2389

2014

Volltextzugriff (PDF)

Kinship dynamics: patterns and consequences of changes in local relatedness

Proceedings of the Royal Society. B, Biological sciences, 2021-08, Vol.288 (1957), p.20211129-20211129

2021

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Aktive Filter

KollektionNexis

ThemaAnimals

ThemaMale

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(115)

Sprache

Englisch
(115)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial

Updated UK Recommendations for HER2 assessment in breast cancer

Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells

Proteogenomics connects somatic mutations to signalling in breast cancer

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

Lasofoxifene in Postmenopausal Women with Osteoporosis

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Increased expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoforms in urinary exosomes in pre-eclampsia

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? - Results of an international retrospective multicenter study

Body-Mass Index and Mortality among Adults with Incident Type 2 Diabetes

A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

Phase III Comparison of Standard Doxorubicin and Cyclophosphamide Versus Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor As Neoadjuvant Therapy for Inflammatory and Locally Advanced Breast Cancer: SWOG 0012

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation

Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001)

Kinship dynamics: patterns and consequences of changes in local relatedness

Aktive Filter

Suchergebnisse filtern